Scientific publications for BioPredictive non-invasive diagnostics
Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.
11/433 Publications
-
The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests.
-
Glycogenic hepatopathy.
-
Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.
-
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
-
Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.
-
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions.
-
Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C.
-
Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study.
-
Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
-
Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
-
Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
Showing the full result list. The page is server-rendered and not paginated.